ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Didier Lardinois
Hans-Beat Ris
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lardinois, D.
Right arrow Articles by Ris, H.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lardinois, D.
Right arrow Articles by Ris, H.-B.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2005;80:268-275
© 2005 The Society of Thoracic Surgeons


Original article: General Thoracic

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small Cell Lung Cancer

Didier Lardinois, MDa,*, Hans Suter, MDb, Hassan Hakki, MDb, Valentin Rousson, PhDd, Daniel Betticher, MDc, Hans-Beat Ris, MDe

a Division of Thoracic Surgery, University Hospital, Zurich
b Division of Thoracic Surgery, University Hospital, Bern
c Department of Oncology, University Hospital, Bern
d Department of Biostatistics, University of Zurich, Zurich
e Department of Thoracic and Vascular Surgery, CHUV, University Hospital, Lausanne, Switzerland

Accepted for publication February 1, 2005.

* Address reprint requests to Dr Lardinois, Division of Thoracic Surgery, University Hospital Zurich, Raemistrasse. 100 8091 Zurich, Switzerland (Email: didier.lardinois{at}usz.ch).

Presented at the Forty-first Annual Meeting of The Society of Thoracic Surgeons, Tampa, FL, Jan 24–26, 2005.

BACKGROUND: Mediastinal lymph-node dissection was compared to systematic mediastinal lymph-node sampling in patients undergoing complete resection for non-small cell lung cancer with respect to morbidity, duration of chest tube drainage and hospitalization, survival, disease-free survival, and site of recurrence.

METHODS: A consecutive series of one hundred patients with non-small-cell lung cancer, clinical stage T1-3 N0-1 after standardized staging, was divided into two groups of 50 patients each, according to the technique of intraoperative mediastinal lymph-node assessment (dissection versus sampling). Mediastinal lymph-node dissection consisted of removal of all lymphatic tissues within defined anatomic landmarks of stations 2–4 and 7–9 on the right side, and stations 4–9 on the left side according to the classification of the American Thoracic Society. Systematic mediastinal lymph-node sampling consisted of harvesting of one or more representative lymph nodes from stations 2–4 and 7–9 on the right side, and stations 4–9 on the left side.

RESULTS: All patients had complete resection. A mean follow-up time of 89 months was achieved in 92 patients. The two groups of patients were comparable with respect to age, gender, performance status, tumor stage, histology, extent of lung resection, and follow-up time. No significant difference was found between both groups regarding the duration of chest tube drainage, hospitalization, and morbidity. However, dissection required a longer operation time than sampling (179 ± 38 min versus 149 ± 37 min, p < 0.001). There was no significant difference in overall survival between the two groups; however, patients with stage I disease had a significantly longer disease-free survival after dissection than after sampling (60.2 ± 7 versus 44.8 ± 8 months, p < 0.03). Local recurrence was significantly higher after sampling than after dissection in patients with stage I tumor (12.5% versus 45%, p = 0.02) and in patients with nodal tumor negative mediastinum (N0/N1 disease) (46% versus 13%, p = 0.004).

CONCLUSION: Our results suggest that mediastinal lymph-node dissection may provide a longer disease-free survival in stage I non-small cell lung cancer and, most importantly, a better local tumor control than mediastinal lymph-node sampling after complete resection for N0/N1 disease without leading to increased morbidity.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
W. Zhong, X. Yang, J. Bai, J. Yang, C. Manegold, and Y. Wu
Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 187 - 195.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Watanabe, T. Mishina, S. Ohori, T. Koyanagi, S. Nakashima, T. Mawatari, Y. Kurimoto, and T. Higami
Is video-assisted thoracoscopic surgery a feasible approach for clinical N0 and postoperatively pathological N2 non-small cell lung cancer?
Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 812 - 818.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
N. Wu, C. Lv, S. Yan, H. Duan, Q. Zheng, J. Wang, H. Xiong, and Y. Yang
Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns
Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 240 - 243.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. A. Whitson, S. S. Groth, and M. A. Maddaus
Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer
Ann. Thorac. Surg., September 1, 2007; 84(3): 1059 - 1065.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. Meyer, C. Cheng, C. Antonescu, E. Pezzetta, A. Bischof-Delaloye, and H.-B. Ris
Successful migration of three tracers without identification of sentinel nodes during intraoperative lymphatic mapping for non-small cell lung cancer
Interactive CardioVascular and Thoracic Surgery, April 1, 2007; 6(2): 214 - 218.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
D. Lardinois, P. De Leyn, P. Van Schil, R. R. Porta, D. Waller, B. Passlick, M. Zielinski, K. Junker, E. A. Rendina, H.-B. Ris, et al.
ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer
Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 787 - 792.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Massard, X. Ducrocq, E. A. Kochetkova, V. A. Porhanov, and M. Riquet
Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 164 - 167.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.